What we do
Atley develops technology for the scalable production of At-211 labeled radiopharmaceuticals. This technology is already enabling the development of new, efficient, and less toxic treatments for disseminated cancer.
Our technology offering spanns the At-211 radiopharmaceutical value chain and is centered around our flagship product: the Atley C100. This product is used to manufacture At-211-based radiopharmaceuticals in a scalable and reproducible manner, and is a pre-requisite for larger clinical trials and commercial roll out of such drug products.
Our product development requires a skilled and cross-functional team, blending mechanical engineering, material sciences, chemistry, software, electrical and electronic engineering, and beyond.
-
Consumables Project Manager – Atley SolutionsHardware & Software · Göteborg, Kristinehamn · Hybrid
About Atley Solutions
Atley Solutions is the world leader in commercial products and services for the development and manufacturing of radiopharmaceuticals based on the alpha emitting radionuclide astatine-211. These radiopharmaceuticals are used in Targeted Alpha Therapy, a promising treatment for disseminated cancer.
Targeted Alpha Therapy has the potential to improve and save millions of lives. For this to happen, Atley is needed.
Already working at Atley Solutions?
Let’s recruit together and find your next colleague.